Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Ellis

Showing results (111-120 of 285) with videos related to

Pageof 29
Sort By:
Clinical Proteomics|January 15, 2024
Kinase inhibitor pulldown assay (KiP) for clinical proteomicsAlexander B Saltzman, Doug W Chan, Matthew V Holt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast CancerIman Doostan, Cansu Karakas, Mehrnoosh Kohansal, et al.
Case Reports in Urology|January 11, 2021
Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint InhibitorRyan S Chiang, Ashton A Connor, Brant A Inman, et al.
JAMA Oncology|September 8, 2018
Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical TrialAman U Buzdar, Vera J Suman, Funda Meric-Bernstam, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2025
Off-label use of alemtuzumab, belatacept, and rapamycin in kidney transplantation-Long-term real-world experienceKateryna Krynychka, Goni Katz-Greenberg, Jennifer S Byrns, et al.
Transplantation|January 17, 2015
Outcomes in kidney transplant recipients from older living donorsBrian R Englum, Matthew A Schechter, William D Irish, et al.
Journal of the National Cancer Institute|October 31, 2019
Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance)Meenakshi Anurag, Mayanne Zhu, Chen Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2016
A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast CancerCynthia X Ma, Cesar Sanchez, Feng Gao, et al.
Archives of Pathology & Laboratory Medicine|October 31, 2014
Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinomaJulie M Jorns, Dafydd G Thomas, Patrick N Healy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survivalDaniel F Hayes, Massimo Cristofanilli, G Thomas Budd, et al.
Pageof 29

Showing results (111-120 of 285) with videos related to

Sort By:
Pageof 29
Clinical Proteomics|January 15, 2024
Kinase inhibitor pulldown assay (KiP) for clinical proteomicsAlexander B Saltzman, Doug W Chan, Matthew V Holt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast CancerIman Doostan, Cansu Karakas, Mehrnoosh Kohansal, et al.
Case Reports in Urology|January 11, 2021
Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint InhibitorRyan S Chiang, Ashton A Connor, Brant A Inman, et al.
JAMA Oncology|September 8, 2018
Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical TrialAman U Buzdar, Vera J Suman, Funda Meric-Bernstam, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2025
Off-label use of alemtuzumab, belatacept, and rapamycin in kidney transplantation-Long-term real-world experienceKateryna Krynychka, Goni Katz-Greenberg, Jennifer S Byrns, et al.
Transplantation|January 17, 2015
Outcomes in kidney transplant recipients from older living donorsBrian R Englum, Matthew A Schechter, William D Irish, et al.
Journal of the National Cancer Institute|October 31, 2019
Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance)Meenakshi Anurag, Mayanne Zhu, Chen Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2016
A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast CancerCynthia X Ma, Cesar Sanchez, Feng Gao, et al.
Archives of Pathology & Laboratory Medicine|October 31, 2014
Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinomaJulie M Jorns, Dafydd G Thomas, Patrick N Healy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survivalDaniel F Hayes, Massimo Cristofanilli, G Thomas Budd, et al.
Pageof 29